Kumagai H - Search Results

1

Successful combination chemotherapy for metastatic inflammatory myofibroblastic tumor: A case report.

Inadomi K, Kumagai H, Takayoshi K, Ariyama H, Kusaba H, Nishie A, Yamamoto H, Takase K, Tanaka M, Sagara K, Okumura Y, Nio K, Nakano M, Arita S, Oda Y, Akashi K, Baba E. Inadomi K, et al. Among authors: kumagai h. Oncol Lett. 2015 Nov;10(5):2981-2985. doi: 10.3892/ol.2015.3708. Epub 2015 Sep 16. Oncol Lett. 2015. PMID: 26722275 Free PMC article.

2

Successful chemoradiotherapy for undifferentiated malignant neoplasm arising from the left pulmonary artery.

Kumagai H, Nio K, Okumura Y, Komoda M, Shirakawa T, Kusaba H, Yasuda S, Odashiro K, Arita S, Ariyama H, Yamada Y, Yamamoto H, Oda Y, Nakamura K, Akashi K, Baba E. Kumagai H, et al. Case Rep Oncol. 2014 Jul 16;7(2):484-90. doi: 10.1159/000365387. eCollection 2014 May. Case Rep Oncol. 2014. PMID: 25202263 Free PMC article.

3

Intraluminal superior vena cava metastasis from adenosquamous carcinoma of the duodenum: A case report.

Takayoshi K, Ariyama H, Tamura S, Yoda S, Arita T, Yamaguchi T, Ozono K, Yamamoto H, Inadomi K, Kumagai H, Tanaka M, Okumura Y, Sagara K, Nio K, Nakano M, Arita S, Kusaba H, Odashiro K, Oda Y, Akashi K, Baba E. Takayoshi K, et al. Among authors: kumagai h. Oncol Lett. 2016 Jan;11(1):605-609. doi: 10.3892/ol.2015.3938. Epub 2015 Nov 18. Oncol Lett. 2016. PMID: 26870254 Free PMC article.

4

Pemetrexed combined with platinum-based chemotherapy for advanced malignant peritoneal mesothelioma: retrospective analysis of six cases.

Nakano M, Kusaba H, Makiyama A, Ariyama H, Arita S, Oda H, Esaki T, Takayoshi K, Uchino K, Tamura S, Kumagai H, Iwama E, Shirakawa T, Mitsugi K, Takaishi S, Akashi K, Baba E. Nakano M, et al. Among authors: kumagai h. Anticancer Res. 2014 Jan;34(1):215-20. Anticancer Res. 2014. PMID: 24403465

5

Efficacy and safety analysis of chemotherapy for advanced colitis-associated colorectal cancer in Japan.

Nio K, Higashi D, Kumagai H, Arita S, Shirakawa T, Nakashima K, Shibata Y, Esaki M, Manabe T, Nagai S, Ueki T, Nakano M, Ariyama H, Kusaba H, Hirahashi M, Oda Y, Esaki T, Mitsugi K, Futami K, Akashi K, Baba E. Nio K, et al. Among authors: kumagai h. Anticancer Drugs. 2016 Jun;27(5):457-63. doi: 10.1097/CAD.0000000000000338. Anticancer Drugs. 2016. PMID: 26771865

6

Bi-cytopenia possibly induced by anti-PD-1 antibody for primary malignant melanoma of the esophagus: A case report.

Inadomi K, Kumagai H, Arita S, Tsuruta N, Takayoshi K, Mishima K, Ota SI, Tanaka M, Okumura Y, Sagara K, Nio K, Nakano M, Uchi H, Yamamoto H, Ariyama H, Kusaba H, Niiro H, Oda Y, Akashi K, Baba E. Inadomi K, et al. Among authors: kumagai h. Medicine (Baltimore). 2016 Jul;95(29):e4283. doi: 10.1097/MD.0000000000004283. Medicine (Baltimore). 2016. PMID: 27442668 Free PMC article.

7

Efficacy and safety of an increased-dose of dexamethasone in patients receiving fosaprepitant chemotherapy in Japan.

Kumagai H, Kusaba H, Okumura Y, Komoda M, Nakano M, Tamura S, Uchida M, Nagata K, Arita S, Ariyama H, Takaishi S, Akashi K, Baba E. Kumagai H, et al. Asian Pac J Cancer Prev. 2014;15(1):461-5. doi: 10.7314/apjcp.2014.15.1.461. Asian Pac J Cancer Prev. 2014. PMID: 24528075 Free article.

8

Reduced dose of salvage-line regorafenib monotherapy for metastatic colorectal cancer in Japan.

Hirano G, Makiyama A, Makiyama C, Esaki T, Oda H, Uchino K, Komoda M, Tanaka R, Matsushita Y, Mitsugi K, Shibata Y, Kumagai H, Arita S, Ariyama H, Kusaba H, Akashi K, Baba E. Hirano G, et al. Among authors: kumagai h. Anticancer Res. 2015 Jan;35(1):371-7. Anticancer Res. 2015. PMID: 25550574

9

Retrospective analysis of cardiovascular diseases related to chemotherapies for advanced solid tumor patients.

Shirakawa T, Nakano M, Nio K, Tamura S, Komoda M, Kumagai H, Uchino K, Odashiro K, Arita S, Shibata Y, Ariyama H, Kusaba H, Akashi K, Baba E. Shirakawa T, et al. Among authors: kumagai h. Anticancer Drugs. 2016 Oct;27(9):891-8. doi: 10.1097/CAD.0000000000000392. Anticancer Drugs. 2016. PMID: 27272413

10

Efficacy analysis of the aprepitant-combined antiemetic prophylaxis for non-round cell soft-tissue sarcoma patients received adriamycin and ifosfamide therapy.

Kusaba H, Kumagai H, Inadomi K, Matsunobu T, Harimaya K, Takayoshi K, Arita S, Ariyama H, Akashi K, Baba E. Kusaba H, et al. Among authors: kumagai h. Medicine (Baltimore). 2016 Dec;95(49):e5460. doi: 10.1097/MD.0000000000005460. Medicine (Baltimore). 2016. PMID: 27930525 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,257 results

Search Page

Filters